Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.1B | 10.8B | 17.2B | 15.7B |
Cost of revenue | 13.4B | 10.4B | 14.9B | 14.2B |
Gross profit | 1.7B | 410M | 2.2B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 985M | 783M | 932M | 613M |
Other operating expenses | 7M | 23M | — | — |
Operating income | 790M | -282M | 1.4B | 992M |
Non operating interest income | ||||
Income | 39M | 54M | — | 66M |
Expense | 753M | 173M | 87M | 170M |
Other income expense | — | — | — | — |
Pretax income | 76M | -401M | 1.3B | 888M |
Tax provision | 4M | -34M | 171M | 154M |
Net income | 72M | -367M | 1.1B | 734M |
Basic EPS | 0.3 | -1.3 | 3.9 | 2.5 |
Diluted EPS | 0.3 | -1.3 | 3.9 | 2.5 |
Basic average shares | 287.5M | 287.5M | 287.5M | 287.5M |
Diluted average shares | 287.5M | 287.5M | 287.5M | 287.5M |
EBITDA | 829M | -228M | 1.4B | 1.1B |
Net income from continuing op. | 959M | — | 1.3B | 1.6B |
Minority interests | 0 | -6M | 7M | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |